AMENDMENT NO. 4 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT AND AMENDMENT NO. 1 TO MARKETING REPRESENTATIVE AGREEMENTMatrix Commercialization Collaboration Agreement and Marketing Representative Agreement • April 7th, 2014 • Orthofix International N V • Surgical & medical instruments & apparatus
THIS AMENDMENT NO. 4 TO MATRIX COMMERCIALIZATION COLLABORATION AGREEMENT AND AMENDMENT NO. 1 TO MARKETING REPRESENTATIVE AGREEMENT (collectively, this “Amendment”) is dated as of the date of the last signature hereunder and effective as of January 1, 2014 (the “Amendment Effective Date”) by and between Musculoskeletal Transplant Foundation, Inc., a non-profit corporation formed under the laws of the District of Columbia, and having a principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”), and Orthofix Holdings, Inc., a corporation organized under the laws of the State of Delaware, and having a principal place of business at 3451 Plano Parkway, Lewisville, Texas 75056 (“Orthofix”) (each, individually, a “Party” and, collectively, the “Parties”).
